medline.ch Onkologie Gynäkologische Tumoren

	Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: a prospective observational study. Ecancermedicalscience Sable S, Wadasadawala T, Kannan M, Sarin R, Pathak R, Krishnamurthy R, Gulia S, Joshi S, Popat P, Shet T. PMID: 42389560 [PubMed - in process]
	Editorial: Immune-related biomarkers in skin and breast cancer: innovations in immunological diagnostics and therapies. Front Immunol Mallardo D, Ottaviano M, Palmieri G, Melucci MT. PMID: 42389541 [PubMed - in process]
	Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways. J Pharm Anal Zhou C, Sarian MN, Tong X, Han R, Anasamy T, Hamezah HS. PMID: 42389487 [PubMed - in process]
	Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention. J Pharm Anal Li X, Li X, Ni S, Zhang X, Liu B. PMID: 42389486 [PubMed - in process]
	Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus Mady R, Tafazal H, Soliman H, Ramadan A, Hajaj M. PMID: 42388957 [PubMed - in process]
	Utility of preoperative outcomes of nutritional evaluation in patients with newly diagnosed ovarian cancer. Gynecol Oncol Rep Mokshagundam S, Bethurum SS, Kleinberg KA, Mahoney MR, Brown AJ, Prescott LS. PMID: 42388720 [PubMed]
	The long road after breast cancer: survivorship issues and long-term treatment effects in young women. Front Oncol Pagliuca M, Buonaiuto R, Verrazzo A, Parola S, Tafuro M, Calderaio C, Martinelli C, Di Rienzo R, Pirolo M, Zurlo C, Tinelli O, Valente R, Cirillo L, Autiero M, D'Aulisio Garigliota ML, Di Monda R, De Angelis C, De Laurentiis M. PMID: 42388620 [PubMed]
	Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Cancer Diagn Progn Sisca L, Polito MG, Iuliani M, Tonini G, Pantano F. PMID: 42388582 [PubMed]
	How BI-RADS v2025 Helps Patients: New Audits and Method of Detection. Korean J Radiol Eby PR, Cohen EO. PMID: 42388095 [PubMed - indexed for MEDLINE]
	Association Between Serum Vitamin D Levels and Insulin Resistance in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. J Obstet Gynaecol Res Guo Q, Du R, Guo C, Ma S. PMID: 42387943 [PubMed - indexed for MEDLINE]
	Enhancing the positive predictive value of early-stage ovarian cancer detection using a two-step machine learning framework. J Transl Med Mikami M, Tanabe K, Nagaki S, Nogami Y, Imanishi T, Ikeda M, Yoshida H, Hasegawa M, Shimada M, Shigeta S, Ishikawa M, Kato M, Saji H, Kobayashi Y, Morisada T, Suzuki N, Ohhara T, Tanaka K, Murakami I, Katahira T, Hayashi C, Grubbs BH, Yamagami W, Matsuo K. PMID: 42387536 [PubMed - as supplied by publisher]
	The relationship between different hormone receptors in breast cancer patients and ovarian response before chemotherapy; a retrospective cohort study. BMC Womens Health Yahyaei A, Kashi S, Hasani F, Vesali S, Hoseini S, Ghaffari F. PMID: 42387472 [PubMed - as supplied by publisher]
	User profiles of young breast cancer survivors on Chinese social media: machine learning-based text mining analysis study. Support Care Cancer Jiang L, Wang X, Liu Y, Zou F, Yi R, Sun Z, Xu J, Hu Y. PMID: 42387063 [PubMed - indexed for MEDLINE]
	The impact of age factors on postoperative limb function recovery in breast cancer. Support Care Cancer Feng Z, Bai Y, Xiao B, Wang G, Cai J, Li W, He Q. PMID: 42386987 [PubMed - indexed for MEDLINE]
	Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi-Omics Analysis and in Vitro Experimental Validation. IET Syst Biol Liu Y, Yuan X, Chen H. PMID: 42386672 [PubMed - indexed for MEDLINE]
	Association between ERCC5 gene rs17655 polymorphism and the risk of breast cancer: an updated meta-analysis. Environ Health Prev Med Luo WS, Shi A, Wang Z, Zheng SZ, Li J. PMID: 42386575 [PubMed - indexed for MEDLINE]
	Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance. Crit Rev Oncol Hematol Piccolo F, Bagni G, Arcangeli A, Lastraioli E. PMID: 42386137 [PubMed - as supplied by publisher]
	Alternative Splicing in Breast Cancer Drug Resistance: Mechanisms, Therapeutic Targeting, and Clinical Translation. Crit Rev Oncol Hematol Xu XL, Zhu ZM, Hu L, Bian XL, Zhu QN. PMID: 42386136 [PubMed - as supplied by publisher]
	Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol Yao H, Zhang Q, Li H, Yin Y, Wang S, Ouyang Q, Sun T, Li W, Wang X, Yan M, Wang B, Cheng J, Tong Z, Wei W, Wang X, Xie W, Sun Z, Yuan P, Geng C, Gan L, Han X, Li W, Zhou S, Yan X, Gao J, Yi T, Wu J, Niu Z, Fu F, Nie J, Wang Y, Zhao B, Wu Z, Zhu Z, Yang Y, Zhao J, Sheng Z, Zhang Y, Cheng L, Zhu X, Song E. PMID: 42385760 [PubMed - as supplied by publisher]
	Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol Shahin MS, Lorusso D, Backes FJ, Barretina-Ginesta MP, O'Malley DM, Forget F, Pothuri B, Hietanen S, McCormick CC, Abadie-Lacourtoisie S, O'Cearbhaill RE, Heitz F, Moore RG, Amit A, Willmott LJ, Pérez MR, Burger RA, Redondo A, Chase DM, Romero I, Moore KN, Vergote I, Cloven N, Haslund CA, Graybill WS, Bergamini A, Berton D, Braicu EI, Lim JT, Golembesky AK, Shtessel L, Monk BJ, González-Martín A. PMID: 42385609 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 331528

Seite 1 von 16577

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung